Ps
PsiOxus (now Akeso)
Abingdon UKFounded 201050 employees
Private CapbiotechAcquiredOncology
Platform: enadenotucirev
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PSI-4605 | PSI-4605 | Preclinical | 1 | BCL-2 | Bladder CaGBM | ||
| Motainavolisib | PSI-5809 | Phase 1 | 1 | CD3 | SLE |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (1)